Literature DB >> 10741643

Influence of the G2 cell cycle block abrogator pentoxifylline on the expression and subcellular location of cyclin B1 and p34cdc2 in HeLa cervical carcinoma cells.

T Theron1, L Böhm.   

Abstract

The progression of cells from G2 into mitosis is mainly controlled by formation of the cyclin B1/p34cdc2 complex. The behaviour of this complex in the irradiation-induced G2 cell cycle delay is still unclear. A prior study demonstrated that the expression of the cyclin B1 protein is reduced by irradiation, and restored to control levels by the methylxanthine drug pentoxifylline, which is a potent G2 block abrogator. The present study shows that irradiation, and 2 mM pentoxifylline affect the expression of the cyclin-dependent kinase p34cdc2 in HeLa cells. Irradiation induces p34cdc2 levels to increase and cyclin B1 levels to decrease. Addition of pentoxifylline at the G2 maximum reverses these trends. This is also evident from the cyclin B1/p34cdc2 ratios which decline after irradiation and are rapidly restored to control levels upon addition of pentoxifylline. It is concluded that cyclin BI and p34cdc2 protein expression are important events and act in concert to control the irradiation induced G2 block. Analysis of cyclin B1 expression in whole cells and in isolated nuclei furthermore show that cyclin B1 is translocated from the nucleus into the cytoplasm when the G2 block is abrogated by pentoxifylline.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10741643      PMCID: PMC6495675          DOI: 10.1046/j.1365-2184.2000.00160.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  37 in total

Review 1.  Creative blocks: cell-cycle checkpoints and feedback controls.

Authors:  A W Murray
Journal:  Nature       Date:  1992-10-15       Impact factor: 49.962

2.  Inhibition of p34cdc2 kinase activation, p34cdc2 tyrosine dephosphorylation, and mitotic progression in Chinese hamster ovary cells exposed to etoposide.

Authors:  R B Lock
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

3.  The role of cyclin synthesis and degradation in the control of maturation promoting factor activity.

Authors:  A W Murray; M J Solomon; M W Kirschner
Journal:  Nature       Date:  1989-05-25       Impact factor: 49.962

4.  Intracellular localization of cyclin B1 during the cell cycle in glioma cells.

Authors:  S Kakino; K Sasaki; A Kurose; H Ito
Journal:  Cytometry       Date:  1996-05-01

5.  Inhibition of p34cdc2 kinase activity by etoposide or irradiation as a mechanism of G2 arrest in Chinese hamster ovary cells.

Authors:  R B Lock; W E Ross
Journal:  Cancer Res       Date:  1990-06-15       Impact factor: 12.701

6.  Mechanism by which caffeine potentiates lethality of nitrogen mustard.

Authors:  C C Lau; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

7.  The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae.

Authors:  T A Weinert; L H Hartwell
Journal:  Science       Date:  1988-07-15       Impact factor: 47.728

8.  Genesis and evolution of high-ploidy tumour cells evaluated by means of the proliferation markers p34(cdc2), cyclin B1, PCNA and 3[H]-thymidine.

Authors:  A Baroja; C de la Hoz; A Alvarez; A Ispizua; J Bilbao; J M de Gandarias
Journal:  Cell Prolif       Date:  1996-02       Impact factor: 6.831

9.  MPF localization is controlled by nuclear export.

Authors:  A Hagting; C Karlsson; P Clute; M Jackman; J Pines
Journal:  EMBO J       Date:  1998-07-15       Impact factor: 11.598

10.  Involvement of p34cdc2 in establishing the dependency of S phase on mitosis.

Authors:  D Broek; R Bartlett; K Crawford; P Nurse
Journal:  Nature       Date:  1991-01-31       Impact factor: 49.962

View more
  5 in total

1.  Influence of irradiation and pentoxifylline on histone H3 phosphorylation in human tumour cell lines.

Authors:  A Binder; L Bohm
Journal:  Cell Prolif       Date:  2002-02       Impact factor: 6.831

2.  The biological effect of pentoxifylline on the survival of human head and neck cancer cells treated with continuous low and high dose-rate irradiation.

Authors:  A Danielsson; E Karlsson; U Delle; K Helou; C Mercke
Journal:  J Cancer Res Clin Oncol       Date:  2005-03-18       Impact factor: 4.553

Review 3.  Aberrant cell cycle regulation in cervical carcinoma.

Authors:  Young Tae Kim; Min Zhao
Journal:  Yonsei Med J       Date:  2005-10-31       Impact factor: 2.759

4.  Pentoxifylline sensitizes human cervical tumor cells to cisplatin-induced apoptosis by suppressing NF-kappa B and decreased cell senescence.

Authors:  Georgina Hernandez-Flores; Pablo C Ortiz-Lazareno; Jose Manuel Lerma-Diaz; Jorge R Dominguez-Rodriguez; Luis F Jave-Suarez; Adriana del C Aguilar-Lemarroy; Ruth de Celis-Carrillo; Susana del Toro-Arreola; Yessica C Castellanos-Esparza; Alejandro Bravo-Cuellar
Journal:  BMC Cancer       Date:  2011-11-10       Impact factor: 4.430

Review 5.  Inhibition of homologous recombination repair with Pentoxifylline targets G2 cells generated by radiotherapy and induces major enhancements of the toxicity of cisplatin and melphalan given after irradiation.

Authors:  Lothar Bohm
Journal:  Radiat Oncol       Date:  2006-05-03       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.